KINDLY MD INC. DL-,001 Logo
US49457M1062
A3EGVG
KDLY

KINDLY MD INC. DL-,001

Caricamento quotazioni...

Previsioni

Non sono disponibili dati degli analisti per questa azienda.


  • Nakamoto keeps chief medical officer after reverse merger with KindlyMD

    Nakamoto retained a Chief Medical Officer because it merged with healthcare provider KindlyMD and must maintain an operating healthcare arm to meet Nasdaq listing rules and avoid shell-company status. The legacy medical business supplies most of Nakamoto’s modest recurring revenue while the crypto treasury side faces scrutiny after a reported $238 million net loss, roughly $200 million in debt and heavy shareholder dilution from recent acquisitions. Management implemented a 1-for-40 reverse split to regain Nasdaq compliance; upcoming insider lock-up releases and the Q2 filing in August will test whether new revenues justify recent deals. » Altro su finance.yahoo.com


  • KindlyMD renames itself Nakamoto and pivots business toward Bitcoin

    KindlyMD has officially changed its name to Nakamoto Inc. and is positioning itself going forward as a Bitcoin-focused company, while the healthcare business will continue under the subsidiary Kindly LLC. Shares and warrants will continue to trade on NASDAQ under the tickers NAKA and NAKAW. Nakamoto says it has built a Bitcoin reserve of more than $500 million and has invested in strategic international investments; the company plans to continue disciplined accumulation of its holdings and to build a portfolio of Bitcoin-native companies. » Altro su de.investing.com


  • KindlyMD announces share buyback program after massive price slump

    KindlyMD approved a share buyback program for its outstanding common shares after the stock lost nearly 98% in six months and is trading close to its 52-week low. Management may make purchases in the market, in privately negotiated transactions and in block trades under Rule 10b-18; the program does not commit to acquiring a fixed number of shares. Despite the buyback plan, the company has high indebtedness and a very low short-term liquidity ratio of 0.13; at the same time KindlyMD secured a loan of USD 203 million to repay a convertible note and appointed new finance chiefs, while B. Riley issued a buy recommendation with a USD 2.00 price target. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, KINDLY MD INC. DL-,001 ha registrato ricavi pari a +31,43M e un utile netto di 116,53M
(EUR) giu 2026
YoY
Ricavi +31,43M 8.967,67%
Utile lordo +18,17M 5.241,81%
Utile netto 116,53M 5.590,36%
EBITDA 99,15M 4.855,53%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
+58,39M
Numero di azioni
6,02M
Massimo/minimo a 52 settimane
+29,83 - +0,56
Dividendi No
Beta
-0,9
Rapporto P/E
0,21
Rapporto PEG
+0,01
Rapporto P/B
+0,65
Rapporto P/S
+3,39

Profilo aziendale

Nome
KINDLY MD INC. DL-,001
CEO
Timothy Pickett
Dipendenti 23

Simboli di borsa

Borsa Simbolo
NASDAQ
KDLY

Scopri gli asset

Gli azionisti di KINDLY MD INC. DL-,001 investono anche nei seguenti asset

🍪

Parqet  usa i cookie. Scopri di più